<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941028-2-00223</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=24 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Supplement 4_Respiratory protection <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Surgery <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Surgical masks for patients <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Training <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Visitors of TB patients <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Respiratory protection program <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Elements <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Periodic evaluation <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Risk assessment <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Case surveillance <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Community TB profile <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Elements of a risk assessment <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Examples <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> How to perform <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Levels of risk <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Periodic reassessment <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Review of TB patient medical records <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Risk area definitions <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Who should conduct <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Risk factors for disease progression <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Risk groups <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Signs and symptoms of active TB <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Skin testing (see PPD testing) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Smears, AFB <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Smoke-tube testing <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Smoke tubes <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Source control <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Sputum induction <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Surgical masks  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 -->  <!-- PJG 0012 frnewline --> For patient transport <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> For patients in ambulatory-care areas or emergency departments <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Visitors of TB patients <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 -->  <!-- PJG 0012 frnewline --> TB infection-control program <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Assigning supervisory responsibility <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Elements of a TB infection-control program <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 -->  <!-- PJG 0012 frnewline --> TB isolation rooms <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Achieving negative pressure <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Anterooms <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Cohorting <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Exhaust <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Grouping <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> HEPA filtration <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> In ambulatory-care areas <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Negative pressure <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Purpose <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Ventilation <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 -->  <!-- PJG 0012 frnewline --> TB patient scheduling <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Tissues <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 -->  <!-- PJG 0012 frnewline --> For hospitalized patients <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> For patients in ambulatory-care areas or emergency departments  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Home-health-care settings <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Transporting TB patients <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Treatment for TB <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Adherence <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Directly observed therapy (DOT) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Dosage recommendations for children and adults <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Drug susceptibility <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> For active TB <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> For latent TB infection <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> During pregnancy <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> For active TB <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> For latent TB infection <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Initiation of <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Preventive therapy <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Regimen options for children and adults <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Supplement 2_Diagnosis and treatment for latent TB infection and active TB <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Treatment for active TB <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Triage <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Tuberculin skin test (see PPD testing) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Ultraviolet germicidal irradiation (UVGI) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Activation of HIV gene promoters <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Applications <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Autopsy rooms <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Carcinogenicity <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Definition <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Determining maximum permissible exposure times <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Duct irradiation <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Educating HCWs <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Effectiveness <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Exposure criteria for UV radiation <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> HCW training issues <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> In ambulatory-care settings <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Installation <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Labelling and posting caution signs <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Limitations <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Maintenance <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Monitoring <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Obtaining consultation before installation <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Precautions <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Recommended exposure limits (RELs) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Safety issues <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Upper-room air irradiation <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> UV radiation, definition <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Ventilation <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 -->  <!-- PJG 0012 frnewline --> Air changes per hour (ACH) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Airflow patterns <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Ambulatory-care areas <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Anterooms <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Autopsy rooms <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Correctional facilities <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Dilution and removal <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Direction of airflow <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Discharge from booths, tents, and hoods <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            